Unknown

Dataset Information

0

Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.


ABSTRACT: In utero hematopoietic cell transplantation (IUHCT) has the potential to cure congenital hematologic disorders including sickle cell disease. However, the window of opportunity for IUHCT closes with the acquisition of T-cell immunity, beginning at approximately 14 weeks gestation, posing significant technical challenges and excluding from treatment fetuses evaluated after the first trimester. Here we report that regulatory T cells can promote alloengraftment and preserve allograft tolerance after the acquisition of T-cell immunity in a mouse model of late-gestation IUHCT. We show that allografts enriched with regulatory T cells harvested from either IUHCT-tolerant or naive mice engraft at 20 days post coitum (DPC) with equal frequency to unenriched allografts transplanted at 14 DPC. Long-term, multilineage donor cell chimerism was achieved in the absence of graft-versus-host disease or mortality. Decreased alloreactivity among recipient T cells was observed consistent with donor-specific tolerance. These findings suggest that donor graft enrichment with regulatory T cells could be used to successfully perform IUHCT later in gestation.

SUBMITTER: Riley JS 

PROVIDER: S-EPMC7094012 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.

Riley John S JS   McClain Lauren E LE   Stratigis John D JD   Coons Barbara E BE   Ahn Nicholas J NJ   Li Haiying H   Loukogeorgakis Stavros P SP   Fachin Camila G CG   Dias Andre I B S AIBS   Flake Alan W AW   Peranteau William H WH  

Blood advances 20200301 6


In utero hematopoietic cell transplantation (IUHCT) has the potential to cure congenital hematologic disorders including sickle cell disease. However, the window of opportunity for IUHCT closes with the acquisition of T-cell immunity, beginning at approximately 14 weeks gestation, posing significant technical challenges and excluding from treatment fetuses evaluated after the first trimester. Here we report that regulatory T cells can promote alloengraftment and preserve allograft tolerance afte  ...[more]

Similar Datasets

| S-EPMC3026737 | biostudies-literature
| S-EPMC4019708 | biostudies-literature
| S-EPMC10838693 | biostudies-literature
| S-EPMC10206581 | biostudies-literature
| S-EPMC7123191 | biostudies-literature
| S-EPMC5761626 | biostudies-literature
| S-EPMC4048633 | biostudies-literature
| S-EPMC2648820 | biostudies-literature
| S-EPMC7596318 | biostudies-literature
| S-EPMC7456221 | biostudies-literature